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ABSTRACT:Chitosan is very useful in everyday life in adsorption, cosmetics, pharmaceuticals, flocculants, 
anticancer and antimicrobial.In this study, chitosan was synthesized from chitin extracted from crayfish. The methods 
such as deproteinization, demineralization, and deacetylation respectively were used in the synthesis of chitosan from 
crayfish. Antimicrobial activity was studied and it was found that chitosan and Moringaleaf powder were good in 
inhibiting the growth of microorganisms; confirmed by the results obtained from the experiments. In evaluating the 
antimicrobial activity, the serial dilution method was used towards Escherichia coli, Staphylococcusaureus, Salmonella 
typhi, Proteus bulgaris and Streptococcus pneumonia. The antibacterial activity of chitosan composite with the leaf 
powder of Moringa oleifera Lam., was determined, using well diffusion, minimum inhibitory concentration (MIC) and 
minimum bactericidal concentration determination method. The composites show the synergistic effect at the higher 
chitosan to lower Moringa concentration and antagonistic effect at higher Moringa to lower chitosan concentrations in all 
the test organisms. The consequences of this research suggest that the chitosan, Moringaleaf powder, and their composites 
can be used to discover an antibacterial agent for developing new pharmaceuticals to control studied human pathogenic 
bacteria responsible for severe illness.Moringaoleiferais widely used in food and folk medicine; while chitosan is widely 
useful in food, detergents, textiles, leather, paper, pharmaceuticals, and cosmetics industries. Synergism/antagonism of 
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Chitosan is regarded as a useful compound in medical 
and pharmaceutical technology. It is widely used in 
nanomedicine, biomedical engineering and 
development of new therapeutic drug delivery systems 
with enhanced bioavailability, specificity and reduced 
pharmacological toxicity attracting the attention of 
entrepreneurs, industrialists, academicians, 
environmentalists, medical scientist, and the general 
populace (Paul et al., 2018). Chitosan is a safe and 
friendly substance for human; therefore, it has become 
of great interest not only as an underutilized resource 
but also as a new functional material of high potential 
in various fields. Some unique properties make 
chitosan an excellent material for the development of 
new industrial applications and recent progress in 
chitosan material is quite noteworthy (Paul et al., 
2018). Chitin and chitosan were attracted marked 
interest due to their biocompatibility, biodegradability, 
and non-toxicity (Hafsa et al., 2015). The need for new 
and effective anti-microbial agents with broad-
spectrum of activity from natural sources is increasing 
day by day (Rahman et al., 2008). In recent years, there 
has been growing interest in research and development 
of new antimicrobial agents from various sources to 
combat microbial resistance (Mounyr et al., 2016). 
This study is indispensable as this natural biopolymer 
composites with Moringa oleifera leaf powder is been 
used on isolates promising to serve as a good 
antimicrobial agent to those microbes that are resistant 
to synthetic drugs with low cost without adverse effect 
on the human system. Hence, this study aimed at the 
synergetic/antagonistic antimicrobial potential of 
chitosan composites with Moringaoliefera leaf 
powder.  
 
MATERIALS AND METHOD 
Sample Collection and Preparation:The Moringa 
oleifera leaf was collected from Samaru Zaria, 
identified in herbarium section of Botany department 
of Ahmadu Bello University, Zaria washed and dried 
at room temperature to constant weight and macerated 
to powder while crayfish was bought from Samaru 
market in Zaria washed and dried in an oven to 
constant weight and grind to a powder. Commercial 
chitosan was purchased from Germany as standard. 
 
Synthesis of Chitosan (Maulin, 2017):The sample 
(crayfish powder) was demineralized by soaking in 
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10% HCl solution for 24 Hrs at 60oC.Deproteinized by 
soaking in 10% NaOH solution for 24Hrs at 60oC. And 
it was allowed to cool for 1 Hr. The solution was then 
filtered and then washed with demineralized water. 
After filtering the solution, the residue was washed 
with demineralized water and the process was 
followed by deacetylation by adding 50% NaOH for 
8Hrs at 60oC and washed with demineralized water to 
neutral pH.Commercial chitosan was obtained from 
Germany and compared with the synthesized chitosan. 
 
Antimicrobial Activity of Chitosan Abdullahi et al., 
(2011): Preparation of stock solution: 200mg/ml of 
the compound was prepared by weighing 2g of the 
moringa powder and dissolved in 10ml of the solvent 
and serial dilution of 100mg/ml, 50mg/ml, 25mg/ml, 
12.5mg/ml and 6.25mg/ml were then prepared. While 
200µg/mlof chitosan was prepared by weighing 0.2g 
and dissolving in 10ml distilled water.and serial 
dilution of 100µg/ml, 50mg/ml, 25µg/ml, 12.5µg/ml 
and 6.25µg/ml were then prepared. 
 
Preparation of Culture Media: This was done by 
weighing 38g of the medium (Mueller Hinton Agar) in 
one litre distilled water with frequent agitation and 
boiled to aid dissolution then autoclaved at 121oC for 
15 minutes and then allowed to cool to 45oC and then 
25ml of the sterilized medium was dispensed into 
sterilized Petri dishes and allowed to solidify. 
 
Standardization of Test Organisms:Pure culture of the 
test microbes (E. coli, S. typhi, S. Aureus, P. bulgaris 
and S. pneumonia) were sub-cultured into normal 
saline and incubated at 37oC for 24 Hrs. 0.5 McFarland 
turbidity standard was used to standardize the test 
microbes’ suspension. 
 
Antimicrobial Susceptibility Test:Agar well diffusion 
was used and 0.1ml standard inoculation of the test 
organism was uniformly streaked into freshly prepared 
Mueller Hinton Agar plate with the aid of a sterile 
swab stick using a sterile cork borer of 6mm diameter, 
two agar well were punched into each agar plate. 0.2ml 
of the compound’s concentrations wereplaced in each 
well respectively and allowed to diffuse into the agar. 
The plates were incubated at 37oC for 24 Hrs. The 
antimicrobial was expressed as the diameter of zone of 
inhibition produced by the compound and reported in 
millimeter (mm) (Abdullahi et al., 2011). 
 
Minimum Inhibitory Concentration (MIC):This was 
done using broth dilution method, 10ml of nutrient 
broth was dispensed into the test tube and sterilized at 
121oC for 15 minutes and allowed to cool. 0.1ml of the 
standard inoculums was dispensed into the broth 
medium. 0.1ml each of the compound serial dilution 
concentration was dispensed and the solution was 
evenly mixed and incubated at 37oC for 24 Hrs. Test 
tubes with no turbidity were noted and the least 
concentration was reported as the MIC value 
(Abdullahi et al., 2011). 
 
Minimum Bactericidal Concentration (MBC): Freshly 
labeled sterile agar plates were used. The MIC test 
tubes of each test organisms were sub-cultured on 
sterile agar plates and then incubated at 37oC for 24 
Hrs. The compound serial concentration with no 
growth was noted and the MBC values reported. All 
results were compared with the standard antibiotic 
(Abdullahiet al., 2011). 
 
RESULTS AND DISCUSSION 
Chitosan samples were prepared with different 
reaction conditions chosen. The chitosan were both 
obtained as white to light red solid powder, insoluble 
in water but soluble in DMSO and acetic acid after 
demineralization, deproteinization and deacetylation 
steps.There is a popular saying that “health is wealth” 
which is a very precious gift of life. Almost everybody 
takes it for granted until we are deprived of it as a result 
of sedentary life style (WHO, 2013).Synthetic drugs 
(antimicrobial drugs) are being used by patients as 
prescribed or not prescribed by physicians for treating 
microbial diseases.  
 
Life-threatening invasive microbial infections are 
major problems in immune-compromised patients. 
Standard antimicrobial agents so far have been quite 
successful, but some of them have limited use due to 
toxicity, drug resistance and their clinical efficacy in 
some invasive microbial infections. The result 
obtained from this work indicated that chitosan, 
moringa leaf powder, and their composites at different 
ratios inhibited the growth of Escherichia coli, 
Staphylococcus aureus, Salmonella typhi, Proteus 
bulgaris and Streptococcus pneumonia with varying 
diameter.  
 
There was a synergistic effect at a higher ratio of 
chitosan to lower ratio of moringa leaf powder while 
the antagonistic effect was observed at a higher ratio 
of moringa powder to lower ratio of chitosan.The 
difference in antimicrobial properties of a plant might 
be attributable to the age of the plant used, freshness 
of plant materials, physical factors (temperature, light, 
water), contamination by field microbes, adulteration 
and substitution of plants, incorrect preparation and 
dosage (Calixto, 2000; Okigbo and Omodamiro, 2006; 
Okigbo and Igwe, 2007). 
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Table 1The zones of inhibition of chitosan composites with Moringa oleifera leaf powder in mm 
 
Key: MD =Moringa in DMSO, CD=Chitosan in DMSO,  1=90%chitosan with 10% moringa, 2=80% chitosan with 20% moringa, 3=70% 
chitosan with 30% moringa, 4=60% chitosan with 40% moringa, 5=50% chitosan with 50% moringa, 6=40% chitosan with 60% moringa, 
7=30% chitosan with 70% moringa, 8=20% chitosan with 80% moringa, 9=10% chitosan with 90% moringa, 
 
Table 2 The minimum inhibition concentration (MIC) 
 
Key: MD =Moringa in DMSO, CD = Chitosan in DMSO,  1=90%chitosan with 10% moringa, 2=80% chitosan with 20% moringa, 3=70% 
chitosan with 30% moringa, 4=60% chitosan with 40% moringa, 5=50% chitosan with 50% moringa, 6=40% chitosan with 60% moringa, 
7=30% chitosan with 70% moringa, 8=20% chitosan with 80% moringa, 9=10% chitosan with 90% moringa, 
 
Table 3The minimum bactericidal concentration (MBC) 
 
Key: MD =Moringa in DMSO, CD = Chitosan in DMSO,  1=90%chitosan with 10% moringa, 2=80% chitosan with 20% moringa, 3=70% 
chitosan with 30% moringa, 4=60% chitosan with 40% moringa, 5=50% chitosan with 50% moringa, 6=40% chitosan with 60% moringa, 
7=30% chitosan with 70% moringa, 8=20% chitosan with 80% moringa, 9=10% chitosan with 90% moringa, 
 
While the activity of chitosan is based on the 
concentration molecular weight, source, degree of 
deacetylation (Paul et al., 2018). Very wide zone of 
inhibition of chitosan composite with Moringa leaf 
powder showed that it had great potential as a remedy 
for infections/diseases caused by Escherichia coli, 
Staphylococcus aureus, Salmonella typhi, Proteus 
bulgaris, and Streptococcus pneumonia. Chitosan is a 
promising material for biomedical as well as food 
science applications, it is a   natural multifunctional 
polymer with unique and versatile properties. It is 
well-known for its significant biological and chemical 
properties. It is regarded as a useful compound in 
medical and pharmaceutical technology; widely used 
in nanomedicine, biomedical engineering and 
development of new therapeutic drug delivery systems 
with enhanced bioavailability, specificity and reduced 
pharmacological toxicity (Paul et al., 2018).  
 
Conclusion: The consequences of this research 
suggest that chitosan, Moringa leaf powder, and their 
composites can be used to discover an antibacterial 
agent for developing new pharmaceuticals to control 
studied human pathogenic bacteria responsible for 
severe illness. Extensive applications of chitosan and 
Moringa in pharmaceutics have been realized because 
they offer unique properties which so far have not been 
attained by many other materials. 
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